The Canadian Organization F_AO1_R Rare Disorders    CORD    IH1_Z AH0 Canadian R_EH1_JH_IH0_S_T_ER0_D CH_EH1_R_IH0_T_IY0 DH_AE1_T IH1_Z AH0 N_EH1_T_W_ER2_K AH1_V AO2_R_G_AH0_N_AH0_Z_EY1_SH_AH0_N_Z HH_UW1 R_EH2_P_R_AH0_Z_EH1_N_T P_IY1_P_AH0_L AH0_F_EH1_K_T_IH0_D B_AY1 R_EH1_R D_IH0_Z_IY1_Z_AH0_Z CORD EH1_S P_ER1_P_AH0_S IH1_Z T_UW1 P_R_AH0_V_AY1_D AH0 S_T_R_AO1_NG K_AA1_M_AH0_N V_OY1_S AE1_D_V_AH0_K_EY2_T_IH0_NG F_AO1_R AH0 HH_EH1_L_TH_K_EH2_R S_IH1_S_T_AH0_M AH0_N_D HH_EH1_L_TH P_AA1_L_AH0_S_IY0 F_AO1_R DH_OW1_Z W_IH1_DH R_EH1_R D_IH0_S_AO1_R_D_ER0_Z     CORD R_EH2_P_R_AH0_Z_EH1_N_T_S DH_AH0 AO1_R_F_AH0_N D_IH0_S_AO1_R_D_ER0_Z K_AH0_M_Y_UW1_N_AH0_T_IY0 IH0_N DH_AH0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AH1_V Canadian Orphan Drug Policy    IH2_N_K_L_UW1_D_IH0_NG DH_AH0 P_R_AH0_P_OW1_Z_D Expensive Drugs F_AO1_R Rare Disorders P_R_OW1_G_R_AE2_M W_IH0_DH_IH1_N DH_AH0 National Pharmaceutical Strategy CORD IH1_Z W_ER1_K_IH0_NG T_UW1 P_R_AH0_M_OW1_T S_T_EY1_T AH1_V DH_AH0 AA1_R_T Newborn Screening IH0_N AO1_L P_R_AA1_V_AH0_N_S_AH0_Z AH0_N_D T_EH1_R_AH0_T_AO2_R_IY0_Z CORD IH1_Z W_ER1_K_IH0_NG T_UW1 EH0_N_SH_UH1_R Canada EH1_S Clinical Trials Registry W_ER1_K_S IH0_F_EH1_K_T_IH0_V_L_IY0 F_AO1_R DH_OW1_Z W_IH1_DH R_EH1_R D_IH0_S_AO1_R_D_ER0_Z CORD IH1_Z K_AH0_M_IH1_T_IH0_D T_UW1 IH2_N_K_R_IY1_S_IH0_NG AE1_K_S_EH2_S T_UW1 JH_AH0_N_EH1_T_IH0_K S_K_R_IY1_N_IH0_NG AH0_N_D JH_AH0_N_EH1_T_IH0_K K_AW1_N_S_AH0_L_IH0_NG F_AO1_R AO1_L R_EH1_R D_IH0_S_AO1_R_D_ER0_Z    Currently    Durhane Wong Rieger IH1_Z DH_AH0 President AH1_V CORD     Their N_AE1_SH_AH0_N_AH0_L AO1_F_AH0_S_AH0_Z AA1_R L_OW1_K_EY2_T_AH0_D IH0_N Toronto    Ontario    W_IH1_DH AE1_N Alberta CH_AE1_P_T_ER0 L_OW1_K_EY2_T_AH0_D IH0_N Edmonton    Alberta    